Strides Chemicals Private Limited - Due diligence report

A 360° intelligence report on Strides: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

2003-01-29 Mumbai, Maharashtra Amalgamated Unlisted Active Compliant
Share
SC Strides Chemicals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Strides — 360° Intelligence Report

Generated from MCA filings & public records
52/100
Trust Score
Moderate

Strides is assessed as Moderate with a Trust Score of 52/100. Strides is a private limited indian non-government company incorporated in 2003, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Strides Chemicals Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
52/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
15/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 3 satisfied (43.89 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India2 48.0 cr
The Hongkong And Shanghai Banking Corporation Limited1 48.0 cr
Compliance Score: 30/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2019 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SUDDAPALLI MURALIKRISHNA 01234567 Director 01/04/2018 6 yrs Approved
DILEEP RAJARAM MAHAJAN 01234567 Director 01/04/2018 6 yrs Approved
SATHISH KUMAR MOHAN RAO 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Solara Active Pharma Sciences Limited
Subsidiaries
-
Group entities
-
Capital events
5 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Solara Active Pharma Sciences Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 15
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 23+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 5 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
14 Aug 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
28 Sep 2018
Director ceased
DILEEP RAJARAM MAHAJAN
Director ceased
SATHISH KUMAR MOHAN RAO
31 Aug 2018
Director appointed
SUDDAPALLI MURALIKRISHNA (Company Secretary)
Director appointed
DILEEP RAJARAM MAHAJAN (Director)
Director appointed
SATHISH KUMAR MOHAN RAO (Director)
Director ceased
VIKESH KUMAR
Director ceased
VENKATA SEETHARAMA RAJU PAKALAPATI
13 Jul 2018
Charge satisfied
The Hongkong And Shanghai Banking Corporation Limited
11 Jul 2018
Director ceased
HEMANT NARAYAN NIKAM
28 Mar 2018
Director ceased
SUNIL SADANAND NADKARNI
03 May 2017
Director ceased
SHASHANK SINHA
06 Apr 2017
Director ceased
YOAV GRINBERG
09 Mar 2017
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 1.54 cr
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 5 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aristonpharmanovatech U24232TG2012PTC083734 Hyderabad, Telangana, India
Raffles Green Pet India Private Limited U37200GJ2013PTC076748 Kheda, Gujarat, India
Piramal Phytocare Limited L73100MH2001PLC132523 Mumbai, Maharashtra, India
Surfactant Products Private Limited U24100GJ2012PTC071130 Ahmedabad, Gujarat, India
Alchemist Group L72200DL1988PLC192643 Delhi, India
Indoaminesltd U24200MH1989PTC051084 Mumbai, Maharashtra, India
Stp Infracare Private Limited U24100WB2009PTC218834 Kolkata, West Bengal, India
Assay Ceramicsand Chemicals Private Limited U26920JH2005PTC011398 Jamshedpur, Jharkhand, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Strides before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Strides: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Strides - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Strides pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Strides - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Strides an active company?

Strides has MCA status “Amalgamated” with a compliance score of 30/100 (Caution Indicated).

Is Strides financially healthy?

Strides has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Strides?

Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Strides?

The ultimate holding entity is Solara Active Pharma Sciences Limited. 3 active director(s) are on record.

Does Strides have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Strides up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Strides?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.